Esperion Therapeutics Inc Cash Flow Quality Index
Esperion Therapeutics Inc cash flow quality index. Esperion Therapeutics Inc (ESPR) has a Cash Flow Quality Index of 0.88x as of March 2024. Operating cash flow of $53.83 Million is below net income of $61.02 Million, suggesting accrual-heavy earnings not yet converted to cash. See ESPR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Esperion Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Esperion Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Esperion Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Esperion Therapeutics Inc generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|